Ankündigung • May 26
Nutritional Growth Solutions Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.5 million. Nutritional Growth Solutions Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 125,000,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0.0012
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Board Change • May 20
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Outside Director Rachel Hirsh Kaduri is the most experienced director on the board, commencing their role in 2023. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Ankündigung • Dec 24
Nutritional Growth Solutions Ltd. has completed a Follow-on Equity Offering in the amount of AUD 2 million. Nutritional Growth Solutions Ltd. has completed a Follow-on Equity Offering in the amount of AUD 2 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 100,000,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0.0012
Transaction Features: Subsequent Direct Listing Ankündigung • Nov 03
Nutritional Growth Solutions Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2 million. Nutritional Growth Solutions Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 100,000,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0.0012
Transaction Features: Subsequent Direct Listing Ankündigung • Aug 05
Nutritional Growth Solutions Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.76 million. Nutritional Growth Solutions Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.76 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 38,000,000
Price\Range: AUD 0.02
Discount Per Security: AUD 0.0012
Transaction Features: Subsequent Direct Listing Ankündigung • Jun 30
Nutritional Growth Solutions Ltd. Announces Resignation of Raanan Shamir as Non-Executive Director of the Company Effective 1 July 2025 Nutritional Growth Solutions Ltd. announced that Raanan Shamir has resigned as Non-Executive Director of the Company effective 1 July 2025. The Board wishes to extend its appreciation to Prof. Shamir for his service and contribution to the Company and wishes him all the best with his future endeavors. Ankündigung • May 23
Nutritional Growth Solutions Ltd., Annual General Meeting, Jun 30, 2025 Nutritional Growth Solutions Ltd., Annual General Meeting, Jun 30, 2025. Ankündigung • Apr 28
Nutritional Growth Solutions Ltd. announced that it expects to receive AUD 1 million in funding Nutritional Growth Solutions Limited has announced that it has entered into binding commitments to issue 1,000,000 convertible notes at a price of AUD 1.00 each for gross proceeds of AUD 1,000,000 on April 28, 2025. The conversion of the convertible notes into ordinary shares in NGS at a price of between AUD 0.03 and AUD 0.025 per ordinary share to occur within 10 business days of NGS shareholders approving their conversion including for the purposes of ASX Listing. Ankündigung • Apr 04
Nutritional Growth Solutions Ltd. Announces CFO Changes On 4 April 2025, Nutritional Growth Solutions Limited announced the appointment of Mr. Manik Pujara as Interim CFO, effective immediately. Mr. Pujara, a Chartered Accountant based in Melbourne and a member of the Australian Institute of Company Directors, has extensive expertise in corporate governance, financial strategy, and change leadership. As a Director at Patison Accountants & Advisors, he has worked closely with businesses to drive growth and enhance operational efficiency. A shareholder in NGS, his alignment with the company's vision underscores his commitment to its success. As part of NGS's ongoing cost-saving initiatives, Mr. Pujara has agreed to receive his compensation in equity. This decision reflects the commitment of the company's leadership, including Directors, the CEO, and the former CFO, who have deferred compensation to support the core team and drive long-term value. Mr. Rob Valerio, who served as Controller since 2019 and as CFO since late 2023, will transition to a supportive role within the finance and accounting team to ensure a smooth handover. Ankündigung • Oct 29
Nutritional Growth Solutions Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.54 million. Nutritional Growth Solutions Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.54 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 18,000,000
Price\Range: AUD 0.03
Discount Per Security: AUD 0.0018
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Board Change • Oct 18
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Outside Director Guy Khavia was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. New Risk • Jul 25
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 5x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$177k). Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Market cap is less than US$10m (AU$3.26m market cap, or US$2.13m). Minor Risk Revenue is less than US$5m (US$3.0m revenue). Ankündigung • Apr 28
Nutritional Growth Solutions Ltd., Annual General Meeting, Jun 25, 2024 Nutritional Growth Solutions Ltd., Annual General Meeting, Jun 25, 2024. Ankündigung • Apr 27
Nutritional Growth Solutions Ltd. has filed a Follow-on Equity Offering in the amount of AUD 1.52499 million. Nutritional Growth Solutions Ltd. has filed a Follow-on Equity Offering in the amount of AUD 1.52499 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 508,330,000
Price\Range: AUD 0.003
Discount Per Security: AUD 0.00018
Transaction Features: Subsequent Direct Listing Reported Earnings • Mar 01
Full year 2023 earnings released: US$0.01 loss per share (vs US$0.033 loss in FY 2022) Full year 2023 results: US$0.01 loss per share (improved from US$0.033 loss in FY 2022). Revenue: US$2.98m (up 1.3% from FY 2022). Net loss: US$2.89m (loss narrowed 32% from FY 2022). Board Change • Jan 02
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Guy Khavia was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Aug 05
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 108% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$4.8m free cash flow). Shares are highly illiquid. Earnings have declined by 32% per year over the past 5 years. Shareholders have been substantially diluted in the past year (108% increase in shares outstanding). Market cap is less than US$10m (AU$2.73m market cap, or US$1.79m). Minor Risk Revenue is less than US$5m (US$2.9m revenue). Board Change • Aug 01
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Outside Director Guy Khavia was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Jul 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Amir Zaidman was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Jul 25
Nutritional Growth Solutions Ltd. Approves Election of Directors Nutritional Growth Solutions Ltd. at its AGM held on July 25, 2023 approved election of Guy Khavia as an outside Director and Rachel Hirsh as an outside Director. Ankündigung • Jun 20
Nutritional Growth Solutions Ltd., Annual General Meeting, Jul 25, 2023 Nutritional Growth Solutions Ltd., Annual General Meeting, Jul 25, 2023, at 14:00 E. Australia Standard Time. Agenda: To consider Re-election of Peter Osborne as Director and approval of Terms of Office; to consider Re-election of Prof Raanan Shamir as Director and approval of Terms of Office; to consider Election of Guy Khavia as an outside Director and approval of Terms of Office; to consider Election of Rachel Hirsh as an outside Director and approval of Terms of Office; to consider ASX Listing Rule 7.1A Approval of Future Issue of Securities; to consider Ratification of Prior Issue of Tranche 1 Placement Share; to consider Approval of Issue of Tranche 2 Placement Shares; and to consider other business matters. Board Change • Apr 21
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Non-Executive Director Amir Zaidman was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Feb 25
Full year 2022 earnings released: US$0.03 loss per share (vs US$0.047 loss in FY 2021) Full year 2022 results: US$0.03 loss per share (improved from US$0.047 loss in FY 2021). Revenue: US$2.95m (down 3.1% from FY 2021). Net loss: US$4.25m (loss narrowed 11% from FY 2021). Board Change • Jan 09
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent Non-Executive Director Amir Zaidman was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Board Change • Nov 16
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent Non-Executive Director Amir Zaidman was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Board Change • Oct 29
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent Non-Executive Director Amir Zaidman was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Board Change • Jul 16
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non-Executive Director Amir Zaidman was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Board Change • Apr 28
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non-Executive Director Amir Zaidman was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. 